Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Porter

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary resultsE Ben-Josef, A T Porter, S Han, et al.
Radiation Research|July 1, 1995
Topical application of WR-2721 achieves high concentrations in the rectal wallE Ben-Josef, J Mesina, L M Shaw, et al.
Seminars in Urologic Oncology|December 19, 1998
The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostateK B Hart, A T Porter, F Shamsa, et al.
International Journal of Cancer|August 7, 1997
Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological originY Q Chen, M Trikha, X Gao, et al.
Reviews in Urology|September 21, 2006
Therapeutic Strategies for Localized Prostate Cancer II: Perineal Prostatectomy, X-Rays, Protons, Neutrons, and Combination BrachytherapyM D Weil, A T Porter, D C Beyer, et al.
Cancer Research|March 1, 1995
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancerX Gao, A Zacharek, A Salkowski, et al.
Cancer Research|June 15, 1997
The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cellsM Trikha, J Timar, S K Lundy, et al.
The Journal of Urology|September 25, 1997
Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen levelJ D Forman, K Meetze, E Pontes, et al.
Oncogene|October 5, 1995
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancerX Gao, Y Q Chen, N Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapyK B Hart, D P Wood, S Tekyi-Mensah, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary resultsE Ben-Josef, A T Porter, S Han, et al.
Radiation Research|July 1, 1995
Topical application of WR-2721 achieves high concentrations in the rectal wallE Ben-Josef, J Mesina, L M Shaw, et al.
Seminars in Urologic Oncology|December 19, 1998
The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostateK B Hart, A T Porter, F Shamsa, et al.
International Journal of Cancer|August 7, 1997
Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological originY Q Chen, M Trikha, X Gao, et al.
Reviews in Urology|September 21, 2006
Therapeutic Strategies for Localized Prostate Cancer II: Perineal Prostatectomy, X-Rays, Protons, Neutrons, and Combination BrachytherapyM D Weil, A T Porter, D C Beyer, et al.
Cancer Research|March 1, 1995
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancerX Gao, A Zacharek, A Salkowski, et al.
Cancer Research|June 15, 1997
The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cellsM Trikha, J Timar, S K Lundy, et al.
The Journal of Urology|September 25, 1997
Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen levelJ D Forman, K Meetze, E Pontes, et al.
Oncogene|October 5, 1995
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancerX Gao, Y Q Chen, N Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapyK B Hart, D P Wood, S Tekyi-Mensah, et al.
Pageof 12